Therapeutic Peptides intermediate
Peptide Ophthalmic Therapeutics
Therapeutic peptides for eye diseases including glaucoma, macular degeneration, and dry eye syndrome.
By Encyclopeptide Editorial | 1 min read
ophthalmic therapeutic glaucoma macular-degeneration eye-disease
Overview
Peptides have emerging roles in ophthalmology, from treating glaucoma to managing retinal diseases.
Major Ophthalmic Peptides
| Drug | Indication | Mechanism |
|---|---|---|
| Latanoprost | Glaucoma | FP receptor agonist |
| Anti-VEGF | AMD, DME | VEGF inhibition |
| Cyclosporine | Dry eye | Immunomodulatory |
Challenges
- Ocular bioavailability
- Topical delivery
- Retinal penetration
- Stability in eye drops
Chemical Identity
| Property | Value |
|---|---|
| Name | Peptide Ophthalmic Therapeutics |
| Category | Therapeutic Peptides |
References
- Encyclopeptide Database. “Peptide Ophthalmic Therapeutics” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Peptide Ophthalmic Therapeutics with interactive quizzes on Wikipept.
Take a Quiz on Wikipept